Country
Netherlands
The European Medicines Agency has started a rolling review of a prospective vaccine for Covid-19 being developed by Oxford University and AstraZeneca Plc on the basis of preliminary data showing that it triggered the production of antibodies and T cells that target the virus.
Full text available to subscribers only. Click here for information on subscribing to MedNous.